Article

Risk of carpal tunnel syndrome is lower with intensive keyboard use

 Persons who engage in intensive computer keyboard use in the workplace are at lower risk for carpal tunnel syndrome (CTS) than those who do not. Keyboard use actually may be protective because repeated low force muscle activity may decrease the risk of edema and increased tissue pressure.

 Persons who engage in intensive computer keyboard use in the workplace are at lower risk for carpal tunnel syndrome (CTS) than those who do not. Keyboard use actually may be protective because repeated low force muscle activity may decrease the risk of edema and increased tissue pressure.

Atroshi and associates conducted a population based study of 2465 persons of working age using a general health status questionnaire. Respondents provided information about their medical history; work activities; and the presence, severity, and frequency of pain, numbness, and tingling in each body region. Those who reported recurrent hand numbness or tingling in the median nerve distribution underwent physical examination and nerve conduction testing.

The prevalence of CTS was 2.6% in the high-keyboard-use group (4 h/d or longer), compared with 2.9% in the moderate-use group (1 to 4 h/d), 4.9% in the low use group (less than 1 h/d), and 5.2% in the no-keyboard-use-at-work group. Older age, higher body mass index, and current cigarette smoking also were associated with a significantly higher prevalence ratio of CTS.

The authors noted that their findings could help physicians in advising patients and in focusing preventive measures on relevant workplaces.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.